Daptomycin and combination daptomycin-ceftaroline as salvage therapy for persistent methicillin-resistant Staphylococcus aureus bacteremia.
作者信息
Cortes-Penfield Nicolas, Oliver Nora T, Hunter Andrew, Rodriguez-Barradas Maria
机构信息
a Department of Medicine , Section of Infectious Diseases, Baylor College of Medicine , Houston , TX , USA.
b Section of Infectious Diseases , Atlanta VA Medical Center , Atlanta , GA , USA.
出版信息
Infect Dis (Lond). 2018 Aug;50(8):643-647. doi: 10.1080/23744235.2018.1448110. Epub 2018 Mar 6.
Abstract
摘要
相似文献
1
Daptomycin and combination daptomycin-ceftaroline as salvage therapy for persistent methicillin-resistant Staphylococcus aureus bacteremia.达托霉素及达托霉素-头孢洛林联合用药作为持续性耐甲氧西林金黄色葡萄球菌菌血症的挽救治疗方案
Infect Dis (Lond). 2018 Aug;50(8):643-647. doi: 10.1080/23744235.2018.1448110. Epub 2018 Mar 6.
2
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: New Therapeutic Approaches.耐甲氧西林金黄色葡萄球菌引起的菌血症：新的治疗方法
Infect Dis Clin North Am. 2016 Jun;30(2):491-507. doi: 10.1016/j.idc.2016.02.009.
3
Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.头孢洛林酯单药治疗耐甲氧西林金黄色葡萄球菌菌血症：一项比较临床结局研究。
Int J Infect Dis. 2017 Apr;57:27-31. doi: 10.1016/j.ijid.2017.01.019. Epub 2017 Jan 25.
4
Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline.使用达托霉素联合头孢洛林对持续性葡萄球菌菌血症进行抗菌挽救治疗。
Clin Ther. 2014 Oct 1;36(10):1317-33. doi: 10.1016/j.clinthera.2014.05.061. Epub 2014 Jul 10.
5
A combination of ceftaroline and daptomycin has synergistic and bactericidal activity in vitro against daptomycin nonsusceptible methicillin-resistant Staphylococcus aureus (MRSA).头孢洛林与达托霉素联用具有协同杀菌作用，可体外抑制达托霉素中介耐甲氧西林金黄色葡萄球菌（MRSA）。
Infect Dis (Lond). 2017 May;49(5):410-416. doi: 10.1080/23744235.2016.1277587. Epub 2017 Jan 24.
6
A comparison of daptomycin alone and in combination with ceftaroline fosamil for methicillin-resistant Staphylococcus aureus bacteremia complicated by septic pulmonary emboli.单独应用达托霉素与达托霉素联合头孢洛林治疗合并感染性肺栓塞的耐甲氧西林金黄色葡萄球菌菌血症的比较。
Eur J Clin Microbiol Infect Dis. 2020 Nov;39(11):2199-2203. doi: 10.1007/s10096-020-03941-5. Epub 2020 Jun 13.
7
Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.达托霉素联合头孢洛林与标准护理单药治疗耐甲氧西林金黄色葡萄球菌菌血症的临床数据。
Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.02483-18. Print 2019 May.
8
Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?与金黄色葡萄球菌菌血症的标准治疗单药疗法相比，达托霉素加头孢洛林是否具有更好的临床疗效？
Antimicrob Agents Chemother. 2019 Oct 22;63(11). doi: 10.1128/AAC.00900-19. Print 2019 Nov.
9
Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia.一名患有耐甲氧西林金黄色葡萄球菌菌血症的青少年使用达托霉素治疗失败。
Pediatr Infect Dis J. 2009 May;28(5):445-7. doi: 10.1097/INF.0b013e3181927891.
10
Ceftaroline as Salvage Monotherapy for Persistent MRSA Bacteremia.头孢洛林作为持续性耐甲氧西林金黄色葡萄球菌菌血症的挽救性单药治疗
Ann Pharmacother. 2016 Dec;50(12):1051-1059. doi: 10.1177/1060028016664361. Epub 2016 Aug 12.
引用本文的文献
1
Adjunctive β-lactams for bacteremia: a narrative review.用于治疗菌血症的辅助性β-内酰胺类药物：一项叙述性综述。
Ther Adv Infect Dis. 2025 Jun 14;12:20499361251343969. doi: 10.1177/20499361251343969. eCollection 2025 Jan-Dec.
2
A review on the screening methods for the discovery of natural antimicrobial peptides.关于发现天然抗菌肽的筛选方法的综述
J Pharm Anal. 2025 Jan;15(1):101046. doi: 10.1016/j.jpha.2024.101046. Epub 2024 Jul 18.
3
Comparison of efficacy and safety between daptomycin plus β-lactam and daptomycin monotherapy for bloodstream infections due to gram-positive cocci: A systematic review and meta-analysis.达托霉素联合β-内酰胺类药物与达托霉素单药治疗革兰氏阳性球菌血流感染的疗效和安全性比较：一项系统评价和荟萃分析。
Heliyon. 2024 Apr 16;10(8):e29811. doi: 10.1016/j.heliyon.2024.e29811. eCollection 2024 Apr 30.
4
New Antimicrobials and New Therapy Strategies for Endocarditis: Weapons That Should Be Defended.感染性心内膜炎的新型抗菌药物及新治疗策略：需加以捍卫的武器
J Clin Med. 2023 Dec 14;12(24):7693. doi: 10.3390/jcm12247693.
5
Persistent Methicillin-Resistant Bacteremia: Host, Pathogen, and Treatment.持续性耐甲氧西林菌血症：宿主、病原体与治疗
Antibiotics (Basel). 2023 Feb 24;12(3):455. doi: 10.3390/antibiotics12030455.
6
Targeted Therapy of Severe Infections Caused by in Critically Ill Adult Patients: A Multidisciplinary Proposal of Therapeutic Algorithms Based on Real-World Evidence.危重症成年患者由[具体病原体未给出]引起的严重感染的靶向治疗：基于真实世界证据的治疗算法多学科建议。
Microorganisms. 2023 Feb 3;11(2):394. doi: 10.3390/microorganisms11020394.
7
Comparing the Outcomes of Ceftaroline plus Vancomycin or Daptomycin Combination Therapy versus Vancomycin or Daptomycin Monotherapy in Adults with Methicillin-Resistant Bacteremia-A Meta-Analysis.头孢洛林联合万古霉素或达托霉素与万古霉素或达托霉素单药治疗耐甲氧西林菌血症成人患者的疗效比较——一项荟萃分析
Antibiotics (Basel). 2022 Aug 15;11(8):1104. doi: 10.3390/antibiotics11081104.
8
Alternative Therapeutic Interventions: Antimicrobial Peptides and Small Molecules to Treat Microbial Keratitis.替代治疗干预措施：用于治疗微生物性角膜炎的抗菌肽和小分子
Front Chem. 2021 Aug 11;9:694998. doi: 10.3389/fchem.2021.694998. eCollection 2021.
9
Use of Ceftaroline in Hospitalized Patients with and without COVID-19: A Descriptive Cross-Sectional Study.头孢洛林在合并及未合并新型冠状病毒肺炎的住院患者中的应用：一项描述性横断面研究。
Antibiotics (Basel). 2021 Jun 23;10(7):763. doi: 10.3390/antibiotics10070763.
10
The Emerging Role of β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.β-内酰胺类药物在耐甲氧西林金黄色葡萄球菌血流感染治疗中的新作用
Antimicrob Agents Chemother. 2020 Jun 23;64(7). doi: 10.1128/AAC.00468-20.
本文引用的文献
1
Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis.耐头孢洛林、耐达托霉素及异质性万古霉素中介的耐甲氧西林金黄色葡萄球菌致感染性心内膜炎
Antimicrob Agents Chemother. 2017 Feb 23;61(3). doi: 10.1128/AAC.01235-16. Print 2017 Mar.
2
A combination of ceftaroline and daptomycin has synergistic and bactericidal activity in vitro against daptomycin nonsusceptible methicillin-resistant Staphylococcus aureus (MRSA).头孢洛林与达托霉素联用具有协同杀菌作用，可体外抑制达托霉素中介耐甲氧西林金黄色葡萄球菌（MRSA）。
Infect Dis (Lond). 2017 May;49(5):410-416. doi: 10.1080/23744235.2016.1277587. Epub 2017 Jan 24.
3
Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial.万古霉素联合β-内酰胺类抗生素治疗耐甲氧西林金黄色葡萄球菌菌血症：一项多中心随机对照试验的初步研究。
Clin Infect Dis. 2016 Jan 15;62(2):173-180. doi: 10.1093/cid/civ808. Epub 2015 Sep 8.
4
Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model.在体外药代动力学/药效学模型中评估头孢洛林单独及联合使用对产生物膜的耐甲氧西林金黄色葡萄球菌的抗菌活性，该菌株对达托霉素和万古霉素敏感性降低
Antimicrob Agents Chemother. 2015 Aug;59(8):4497-503. doi: 10.1128/AAC.00386-15. Epub 2015 May 18.
5
Daptomycin non-susceptible, vancomycin-intermediate Staphylococcus aureus endocarditis treated with ceftaroline and daptomycin: case report and brief review of the literature.用头孢洛林和达托霉素治疗的达托霉素不敏感、万古霉素中介金黄色葡萄球菌心内膜炎：病例报告及文献简要综述
Infection. 2015 Dec;43(6):751-4. doi: 10.1007/s15010-015-0763-0. Epub 2015 Mar 25.
6
Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis.万古霉素最低抑菌浓度与金黄色葡萄球菌血流感染患者死亡率之间的关系：系统评价和荟萃分析。
JAMA. 2014 Oct 15;312(15):1552-64. doi: 10.1001/jama.2014.6364.
7
Observation of "seesaw effect" with vancomycin, teicoplanin, daptomycin and ceftaroline in 150 unique MRSA strains.观察 150 株独特的耐甲氧西林金黄色葡萄球菌（MRSA）菌株中万古霉素、替考拉宁、达托霉素和头孢洛林的“跷跷板效应”。
Infect Dis Ther. 2014 Jun;3(1):35-43. doi: 10.1007/s40121-014-0023-0. Epub 2014 Jan 18.
8
Predictors and clinical outcomes of persistent methicillin-resistant Staphylococcus aureus bacteremia: a prospective observational study.耐甲氧西林金黄色葡萄球菌菌血症持续时间的预测因素和临床转归：一项前瞻性观察研究。
Korean J Intern Med. 2013 Nov;28(6):678-86. doi: 10.3904/kjim.2013.28.6.678. Epub 2013 Oct 29.
9
Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model.头孢洛林增加膜结合，并增强达托霉素对药代动力学/药效学模型中介导万古霉素耐药金黄色葡萄球菌的活性。
Antimicrob Agents Chemother. 2013 Jan;57(1):66-73. doi: 10.1128/AAC.01586-12. Epub 2012 Oct 15.
Zotero 插件